Similar articles

• Parkinson's disease.

  Clarke C, Moore AP. Clarke C, et al. Clin Evid. 2002 Jun;(7):1208-20. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):1370-85. PMID: 12230738 Updated. Review. No abstract available.
• [Parkinson disease. Directed use of modern therapy].

  Möller JC, Wächter T, Oertel WH. Möller JC, et al. MMW Fortschr Med. 2001 May 28;143 Suppl 2:45-50. MMW Fortschr Med. 2001. PMID: 11434257 German.
• Future therapies for Parkinson's disease.

  Hauser RA, Lyons KE. Hauser RA, et al. Neurol Clin. 2004 Oct;22(3 Suppl):S149-66. doi: 10.1016/j.ncl.2004.05.005. Neurol Clin. 2004. PMID: 15501363 Review. No abstract available.
• [The role of dopaminagonists in the treatment of Parkinson's disease].

  Ransmayr G. Ransmayr G. Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. doi: 10.1024/0369-8394.94.42.1633. Praxis (Bern 1994). 2005. PMID: 16277084 German.
• Medical hazards of the internet: gambling in Parkinson's disease.

  Larner AJ. Larner AJ. Mov Disord. 2006 Oct;21(10):1789. doi: 10.1002/mds.21057. Mov Disord. 2006. PMID: 16941457 No abstract available.